Polyganics

First Patients Treated in First-in-Human Trial for Innovative Liver and Pancreas Sealant Patch

Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announced treatment of the first patients in its first-in-human study for ACTISEAL, its Liver and Pancreas Sealant Patch.
POLYGANICS Rozenburglaan 15A 9727 DL Groningen The Netherlands

+31 50 588 6 588